Clinical trial
A Randomised Controlled Trial of Continuing Immunoglobulin Therapy, or Stopping With or Without Prophylactic Antibiotics, on Infection Rate in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies.
NCT05678621 is registered in ClinicalTrials.gov with Monash University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised Controlled Trial of Continuing Immunoglobulin Therapy, or Stopping With or Without Prophylactic Antibiotics, on Infection Rate in Patients With Acquired Hypogammaglobulinemia Secondary to Haematological Malignancies.
- Lead sponsor
- Monash University
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- November 30, 2022
- Completion date
- April 30, 2027
- Enrollment
- 300 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
haematological malignancy, hypogammaglobulinemia